Extrawell Pharma files board, committee and disclosure-responsible management list
PUBT · 3d ago
Share
Listen to the news
- Extrawell updated its board and committee composition in a filing dated Aug. 28, 2026.
- Executive directors: Dr. Xie Yi (chairman), Dr. Guo Yi (CEO), Mr. Cheng Yong (deputy CEO), Ms. Wong Sau Kuen.
- Independent non-executive directors: Ms. Jin Song, Dr. Zeng Li, Ms. Yang Xiaorong.
- Audit Committee: Ms. Jin Song (chair), Dr. Zeng Li, Ms. Yang Xiaorong.
- Remuneration Committee chaired by Ms. Jin Song; members include Dr. Zeng Li, Ms. Yang Xiaorong, Dr. Xie Yi.
- Nomination Committee chaired by Dr. Xie Yi; members include Ms. Jin Song, Dr. Zeng Li, Ms. Yang Xiaorong.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12304667), on August 28, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending